← Open Payments lookup

RONALD GARBUTT: Open Payments

NPI 1790776979 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$387 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $387

Food & beverage: $387
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.3$99
Alkermes, Inc.3$82
Otsuka America Pharmaceutical, Inc.2$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Takeda Pharmaceuticals U.S.A., Inc.1$21
Otsuka Pharmaceutical Development & Commercialization, Inc.1$20
Neurocrine BioSciences, Inc.1$18
Lundbeck LLC1$18
E.R. Squibb & Sons, L.L.C.1$17

Products named: FANAPT, REXULTI, LYBALVI, CAPLYTA, TRINTELLIX, REJOYN, ARISTADA, INGREZZA.

Industry payments across PA — which companies pay providers there.